Comprehensive pancancer analysis reveals that LPCAT1 is a novel predictive biomarker for prognosis and immunotherapy response
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is upregulated in many cancers, correlating with poor prognosis and influencing tumor progression and immune response. Targeting LPCAT1 may improve cancer treatment outcomes and immunotherapy efficacy.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is vital for phospholipid metabolism and biofilm integrity.
- Its role in diverse cancer types and its impact on antitumor immunity remain largely uncharacterized.
Purpose Of The Study
- To comprehensively investigate the role of LPCAT1 in various cancers.
- To explore its association with prognosis, biological functions, and antitumor immunity.
Main Methods
- Analysis of public databases for LPCAT1 expression, genetic alterations, methylation, and prognostic value.
- In vitro experiments in glioma, breast, and liver cancer cells to validate LPCAT1 function.
- Functional enrichment analysis and assessment of immune cell infiltration and immune checkpoint gene expression.
Main Results
- LPCAT1 is upregulated across multiple cancers, often with amplification mutations, and linked to poorer patient prognosis.
- In vitro studies showed that LPCAT1 inhibition increases apoptosis and suppresses proliferation and migration in cancer cells.
- LPCAT1 expression correlates with immune cell infiltration, immune checkpoint genes, and is higher in immunotherapy responders.
Conclusions
- LPCAT1 plays a significant role in tumor progression and immune regulation.
- LPCAT1 is a promising biomarker for predicting cancer patient outcomes and response to immunotherapy, especially in combination with PDL1.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...